Commonwealth Equity Services
MGRM

Commonwealth Equity Services’s Monogram Orthopaedics MGRM Stock Holding History

Commonwealth Equity Services’s Portfolio MGRM Stock Details MGRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-39,992
Closed -$235K – 4396
2025
Q3 		$235K Sell
39,992
-865
-2% -$4.62K ﹤0.01% 3836
2025
Q2 		$118K Sell
40,857
-358
-0.9% -$965 ﹤0.01% 4036
2025
Q1 		$121K Sell
41,215
-413
-1% -$1.09K ﹤0.01% 3961
2024
Q4 		$99K Buy
41,628
+7,366
+21% +$17.3K ﹤0.01% 3907
2024
Q3 		$91K Buy
34,262
+15,258
+80% +$39.7K ﹤0.01% 3880
2024
Q2 		$41K Buy
19,004
+3,686
+24% +$8.08K ﹤0.01% 3912
2024
Q1 		$37K Buy
+15,318
New +$45.2K ﹤0.01% 3924

Commonwealth Equity Services's MGRM Position: Q4 2025 in Review

Commonwealth Equity Services sold out of Monogram Orthopaedics (MGRM) in Q4 2025, closing a stake of 39,992 shares — an estimated $235K sold.

Commonwealth Equity Services first reported a position in MGRM in Q1 2024 and held it in 7 quarters. The position peaked at $235K in Q3 2025. 0 funds tracked by Wall St. Rank hold MGRM as of Q4 2025.

  • Commonwealth Equity Services reported no remaining Monogram Orthopaedics position as of Q4 2025 after selling out during the quarter.
  • Commonwealth Equity Services sold 39,992 Monogram Orthopaedics shares in Q4 2025, an estimated $235K.
  • Commonwealth Equity Services first reported a position in Monogram Orthopaedics in Q1 2024 and held it in 7 quarters.
  • Commonwealth Equity Services's Monogram Orthopaedics position peaked at $235K in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Monogram Orthopaedics as of Q4 2025.

Based on Commonwealth Equity Services's 13F filing for Q4 2025, filed 12 Feb 2026.